(0.00%) 5 478.75 points
(-0.01%) 38 814 points
(0.05%) 19 930 points
(0.26%) $80.54
(0.97%) $2.82
(0.13%) $2 332.00
(-0.31%) $29.30
(-0.02%) $970.70
(0.03%) $0.932
(-0.10%) $10.64
(0.09%) $0.788
(-1.87%) $86.80
Live Chart Being Loaded With Signals
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis...
Stats | |
---|---|
Šios dienos apimtis | 750 720 |
Vidutinė apimtis | 673 493 |
Rinkos kapitalizacija | 1.63B |
EPS | $-0.0249 ( Q4 | 2024-05-08 ) |
Kita pelno data | ( $0 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-22.99 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0200 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-13 | Jones Evan/ Fa | Buy | 11 473 | Common Stock |
2024-06-13 | Barr Eliav | Buy | 11 473 | Common Stock |
2024-06-13 | Holstein Jens | Buy | 11 473 | Common Stock |
2024-06-13 | Bhanji Muna | Buy | 11 473 | Common Stock |
2024-06-13 | Epstein Robert S | Buy | 11 473 | Common Stock |
INSIDER POWER |
---|
41.75 |
Last 99 transactions |
Buy: 1 110 167 | Sell: 494 154 |
Tūris Koreliacija
Veracyte Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
SPTN | 0.938 |
SGBX | 0.938 |
RRGB | 0.931 |
AGRX | 0.928 |
AMCX | 0.924 |
BIIB | 0.922 |
VIOT | 0.921 |
CNXC | 0.919 |
TBNK | 0.919 |
QNRX | 0.918 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
MTEK | -0.921 |
KINS | -0.918 |
VNOM | -0.911 |
JSPR | -0.91 |
TAYD | -0.907 |
CDRO | -0.907 |
JVA | -0.904 |
RNA | -0.903 |
IMPPP | -0.903 |
SHLD | -0.901 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Veracyte Inc Koreliacija - Valiuta/Žaliavos
Veracyte Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $361.05M |
Bruto pelnas: | $223.15M (61.81 %) |
EPS: | $-1.020 |
FY | 2023 |
Pajamos: | $361.05M |
Bruto pelnas: | $223.15M (61.81 %) |
EPS: | $-1.020 |
FY | 2022 |
Pajamos: | $296.54M |
Bruto pelnas: | $194.95M (65.74 %) |
EPS: | $-0.510 |
FY | 2021 |
Pajamos: | $219.51M |
Bruto pelnas: | $145.11M (66.11 %) |
EPS: | $-1.419 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Veracyte Inc
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.